Long-term real-world evidence of CPX-351 of high-risk patients with AML identified high rate of negative MRD and prolonged OS
CPX-351治疗高危急性髓系白血病(AML)患者的长期真实世界证据表明,该疗法可显著提高微小残留病灶(MRD)阴性率并延长总生存期(OS)。
期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2024014279
Cluzeau, Thomas; Guolo, Fabio; Chiche, Edmond; Minetto, Paola; Rahme, Ramy; Bertoli, Sarah; Fianchi, Luana; Micol, Jean-Baptiste; Gottardi, Michele; Peterlin, Pierre; Galimberti, Sara; Thomas, Xavier; Rizzuto, Giuliana; Legrand, Olivier; Rondoni, Michela; Raffoux, Emmanuel; Bertani, Giambattista; Caulier, Alexis; D'Argenio, Michelina; Bonmati, Caroline; Billio, Atto; Lejeune, Caroline; Scappini, Barbara; Pigneux, Arnaud; Zappasodi, Patrizia; Recher, Christan; Grimaldi, Francesco; Ades, Lionel; Lemoli, Roberto M